Introduction
Many people ask, as they should, whether Legit.Health has been tested, clinically validated or peer-reviewed.
In this short article, we lay out the scientific evidence related to the performance of our solution. This is an ongoing process, so stay tuned for updates in this regard.
Short answer
Yes, Legit.Health has been clinically validated in several Spanish hospitals by doctors of renown in each of their specialities.
The clinical validation studies that prove our technology works range from assessing its efficiency at improving the diagnosis and follow-up processes, both in general and also in pathology-specific studies, which test our tool’s sensibility and precision regarding that particular condition.
Several of our clinical validation studies have already been published in well-known medical journals, both in the fields of dermatology and computer science, and the rest are at different stages of the publishing process.
Do you want to see the clinical A.I. technology in action?
Long answer
The technology behind Legit.Health is complex and multifaceted. Behind a seemingly simple process for the user, several algorithms interact with each other not only with the aim of identifying the disease and its severity, but also to increase the adequacy of referral, ensure the image quality, and measure the effectiveness of treatment.
Each one of them has gone through or is going through clinical validation. We cannot divulge information about all the instances of clinical validation we are involved in, but we can give you a taste:
For example, we have recently published with the help of Dr Ramon Grimalt our ASCORAD paper in JID Innovations.
Automatic SCORAD for Atopic Dermatitis
Automatic Hidradenitis Suppurativa Scoring

We also have made public our poster about AIHS4, our Automatic Hidradenitis suppurativa scoring system in collaboration with Dr Fernando Alfageme in the 2022 Spanish national dermatology congress.
Automatic Urticaria Activity Score
Our work on the AUAS, was presented at the AEDV 2021 and it is being peer-reviewed in the Journal of Investigative Dermatology.
Dermatology Image Quality Assessment (DIQA)
Dermatology Image Quality Assessment (DIQA): Artificial Intelligence to ensure the clinical utility of images for remote consultations and clinical trials
Automatic Psoriasis Area and Severity Index

Our work on the APASI, the Automatic Psoriasis Scoring System our team developed, got recognized by the AEDV with an award in the medical image category.
Additionally, we are taking part in several clinical trials regarding some of our technological advancements.
We also are pushing to implement our technology into new areas of medical knowledge, like the case of our collaboration with Dr Sergio Vañó and his team at the Ramon y Cajal Hospital, which are spearheading the application of A.I. technology to measure the severity of frontal fibrosing alopecia (FFA).
Another instance of Legit.Health’s team expanding the scope of the deep learning algorithmic technology applied to medical since would be facial palsy. Dr. Goiztidi Díaz Basterra, Dr. Luis Barbier Herrero y Dra. Estíbaliz Ortiz de Zárate is leading an effort at the Basurto Hospital to apply this revolutionary technology to this field.
A good example would be the extensive clinical trial that Dr Leticia Calzado is leading at the Torrejon Hospital, where she and her team are validating the computer-assisted diagnosis process with excellent results.
Do you want to see the clinical A.I. technology in action?
In some cases, the promising results have pushed the research teams to expand the scope of the study. Like the study taking part in both the Cruces Hospital and Basurto Hospital under the scrutiny of Drs. Jesús Gardeazabal and Rosa María Izu Belloso studying the options of computer-assisted diagnosis in the case of Melanoma.
Get access now
This free 23-day trial of Legit.Health gives clinics and hospitals a hands-on look at how to drive increased adherence and improve patient outcomes, as well as improving efficiency and overall quality of life.
